Ambu A/S (OTCMKTS:AMBBY – Get Free Report) declared a dividend on Tuesday, November 5th, NASDAQ reports. Stockholders of record on Friday, December 6th will be given a dividend of 0.0557 per share on Monday, December 23rd. The ex-dividend date of this dividend is Friday, December 6th.
Ambu A/S Price Performance
AMBBY stock traded down $0.32 during trading on Wednesday, reaching $17.12. 582 shares of the company were exchanged, compared to its average volume of 711. Ambu A/S has a 52-week low of $12.65 and a 52-week high of $22.65. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.51 and a current ratio of 2.52. The company has a market cap of $4.02 billion and a P/E ratio of 71.33. The stock’s 50 day moving average price is $19.02 and its 200 day moving average price is $19.05.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its earnings results on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 8.09% and a net margin of 8.55%. The company had revenue of $199.56 million for the quarter.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
See Also
- Five stocks we like better than Ambu A/S
- Insider Selling Explained: Can it Inform Your Investing Choices?
- What a Trump Win Looks Like for the Market Now and Into 2025
- How to Invest in Blue Chip Stocks
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.